⌘K

Home/Filings/4/0001209191-21-022059

4//SEC Filing

Ekins Sean 4

Accession 0001209191-21-022059

CIK 0001762303other

View on SEC.gov Company Profile

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 4:07 PM ET

Size

5.5 KB

Accession

0001209191-21-022059

Insider Transaction Report

Form 4

Period: 2021-03-17

AVITA Medical, Inc.RCEL

Sr. VP of Finance

Transactions

Award
Stock Options (Right to Buy)
2021-03-17+30,000→ 30,000 total
Exercise: $21.93Exp: 2031-03-17→ Common Stock (30,000 underlying)

Footnotes (1)

[F1]These Stock Options become exercisable in four equal annual installments beginning on March 17, 2022.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

AVITA Medical, Inc.

CIK 0001762303

Entity typeother

Related Parties

1

filerCIK 0001833454

Filing Metadata

Form type: 4
Filed: Mar 18, 8:00 PM ET
Accepted: Mar 19, 4:07 PM ET
Size: 5.5 KB

View on SEC.gov